MedPath

Safety And Efficacy Results of Percutaneous Renal Stent Implantation in Ectatic and Aneurysmatic Coronary Arteries

Phase 4
Completed
Conditions
Coronary Artery Ectasia
Interventions
Drug: Renal stent
Registration Number
NCT05410678
Lead Sponsor
Bursa Postgraduate Hospital
Brief Summary

The aim of this study was to evaluate the efficacy and safety of renal stents implanted in ectatic/aneurysmatic coronary arteries.

Detailed Description

In total, 18 patients (renal stent group) who underwent renal stent implantation in ectatic/aneurysmatic coronary arteries requiring percutaneous coronary intervention (PCI) and 45 patients who underwent large-sized bare metal coronary stent (BMCS) implantation (BMCS group) at our centre between 2015 and 2020 were included in the study. Control coronary angiography (CAG) was performed during the follow-up of these patients, and angiography-guided quantitative measurements were performed during PCI. The primary endpoints were myocardial infarction and cardiovascular mortality, and the secondary endpoints were restenosis and all-cause mortality.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
63
Inclusion Criteria
  • Acute coronary syndrome patients

    • 18 year age
  • ectatic/aneurysmatic coronary arteries

Exclusion Criteria
  • Patients who underwent elective procedures,
  • experienced unsuccessful attempts
  • referred to surgical revascularization

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
renal stent groupRenal stentAcute coronary patients treatment with renal stent
BMCS groupRenal stentAcute coronary patients treatment with bare-metal stent
Primary Outcome Measures
NameTimeMethod
primary endpoints2 year

Rate of myocardial infarction and cardiovascular mortality

Secondary Outcome Measures
NameTimeMethod
secondary endpoints2 year

Rate of restenosis and all-cause mortality

© Copyright 2025. All Rights Reserved by MedPath